Table 1 Demographic data of study participants
Variables | Community pharmacists | Clinical pharmacists | General practitioners | P-value |
|---|---|---|---|---|
Gender | ||||
Male | 106 (39.0%) | 89 (40.1%) | 103 (47.7%) | 0.051 |
Female | 166 (61.0%) | 133 (59.9%) | 113 (52.3%) | |
Age | ||||
Range | 21–57 | 21–55 | 23–49 | 0.0001 |
Mean ± SD | 26.15 ± 5.54 | 28.60 ± 6.73 | 27.12 ± 4.89 | |
Residence | ||||
Upper Egypt | 97 (35.7%) | 89 (40.0%) | 86 (39.8%) | 0.773 |
Center | 92 (33.8%) | 69 (31.0%) | 63 (29.2%) | |
Delta | 83 (30.5%) | 64 (29.0%) | 67 (31.0%) | |
Recent medical education on hMPV | ||||
Yes | 54 (20.0%) | 51 (23.0%) | 52 (24.1%) | 0.659 |
No | 218 (80.0%) | 171 (77.0%) | 164 (75.9%) | |
Egypt reported positive cases | ||||
Yes | 111 (40.8%) | 107 (48.2%) | 109 (50.5%) | 0.045 |
No | 49 (18.0%) | 29 (13.1%) | 20 (9.3%) | |
I do not know | 112 (41.2%) | 86 (38.7%) | 87 (39.2%) | |
Positive cases in nearby countries | ||||
Yes | 115 (42.3%) | 111 (50.0%) | 120 (55.6%) | 0.061 |
No | 25 (9.2%) | 16 (7.2%) | 13 (6.0%) | |
I do not know | 132 (48.5%) | 95 (42.8%) | 83 (38.4%) | |
Total knowledge scores | ||||
Range | 4–23 | 5–24 | 4–23 | 0.793 |
Mean ± SD | 12.67 ± 3.48 | 12.86 ± 3.22 | 12.68 ± 3.20 | |